Bob Löwenberg
- Hematology top 0.01%
- Acute Myeloid Leukemia Research 295
- Hematopoietic Stem Cell Transplantation 92
- Chronic Myeloid Leukemia Treatments 62
- Multiple Myeloma Research and Treatments 33
- Genetics top 0.05%
- Myeloproliferative Neoplasms: Diagnosis and Treatment 35
- Oncology top 0.1%
- Immunology top 0.2%
- Immune Cell Function and Interaction 44
-
- Acute Lymphoblastic Leukemia research 70
-
- Retinoids in leukemia and cellular processes 45
- Co-authors
- Ruud DelwelPeter J.M. ValkAlan K. BurnettClaudia Erpelinck-VerschuerenGert J. OssenkoppelePieter SonneveldJan J. CornelissenElihu H. Estey
- Cited by
- HematologyGeneticsOncology
- Journals
- Blood (183 papers)British Journal of Haematology (35 papers)Journal of Clinical Oncology (21 papers)
- Partner nations
- NetherlandsUnited StatesGermany
In The Last Decade
Bob Löwenberg
528 papers receiving 35.0k citations
Hit Papers
Peers
Comparison fields: 5 of 167
- Hematology 23.5k
- Genetics 5.9k
- Oncology 8.0k
- Immunology 5.4k
- Public Health, Environmental and Occupational Health 6.5k
Countries citing papers authored by Bob Löwenberg
This map shows the geographic impact of Bob Löwenberg's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Bob Löwenberg with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Bob Löwenberg more than expected).
Fields of papers citing papers by Bob Löwenberg
This network shows the impact of papers produced by Bob Löwenberg. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Bob Löwenberg. The network helps show where Bob Löwenberg may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Bob Löwenberg, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2024 | 3 | |
| 2 | 2023 | 19 | |
| 3 | 2015 | 43 | |
| 4 | 2014 | 146 | |
| 5 | 2010 | 74 | |
| 6 | 2010 | 262 | |
| 7 | Diagnosis and management of acute myeloid leukemia in adults: recommendations from an international expert panel, on behalf of the European LeukemiaNetbreakdown → | 2009 | 2350 |
| 8 | 2008 | 121 | |
| 9 | 2007 | 345 | |
| 10 | 2007 | 52 | |
| 11 | 2006 | 19 | |
| 12 | Final analysis of a randomized study on the value of fludarabine in addition to ARA-C and G-CSF in the treatment of patients with high risk myelodysplastic syndromes and elderly AML | 2002 | 2 |
| 13 | A randomized study on the value of Fludarabine in addition to ARA-C and G-CSF in the treatment of patients with high risk myelodysplastic syndromes and elderly AML. A report from the Dutch-Belgian hemato-oncology cooperative group (HOVON) | 2001 | 2 |
| 14 | P-gp and mrp activities in relation to treatment outcome in acute myeloid leukemia. | 1999 | 1 |
| 15 | A randomized study of granulocyte-colony stimulating factor applied during and after chemotherapy in patients, with poor risk myelodysplastic syndromes: A final report from the Hovon Cooperative Group. | 1998 | 1 |
| 16 | 1985 | 2 | |
| 17 | Bone Marrow Transplan- tation: Biological Mechanisms and Clinical Practice | 1985 | 25 |
| 18 | Influence of interferon preparations on the proliferative capacity of human and mouse bone marrow cells in vitro. | 1978 | 65 |
| 19 | Induction of proliferation of haemopoietic stem cells in culture. | 1977 | 9 |
| 20 | Influence of genetic resistance and silica particles on survival after bone marrow transplantation. | 1976 | 12 |
About Bob Löwenberg
Bob Löwenberg is a scholar working on Hematology, Genetics and Immunology, having authored 534 papers that have together received 35.9k indexed citations. Recurring topics across this work include Acute Myeloid Leukemia Research (295 papers), Hematopoietic Stem Cell Transplantation (92 papers), Acute Lymphoblastic Leukemia research (70 papers), Chronic Myeloid Leukemia Treatments (62 papers), Retinoids in leukemia and cellular processes (45 papers), Immune Cell Function and Interaction (44 papers), Myeloproliferative Neoplasms: Diagnosis and Treatment (35 papers) and Multiple Myeloma Research and Treatments (33 papers). The work is most often cited by research in Hematology (23.5k citations), Genetics (5.9k citations) and Oncology (8.0k citations). Bob Löwenberg has collaborated with scholars based in Netherlands, United States and Germany. Frequent co-authors include Ruud Delwel, Peter J.M. Valk, Alan K. Burnett, Claudia Erpelinck-Verschueren, Gert J. Ossenkoppele, Pieter Sonneveld, Jan J. Cornelissen, Elihu H. Estey, James R. Downing and Miguel Á. Sanz. Their work appears in journals such as Blood, British Journal of Haematology, Journal of Clinical Oncology, Leukemia and Leukemia Research.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.